Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Contraceptive Technology Update

RSS  

Articles

  • Face facts about effectiveness of ECPs

    In 1992, reproductive health advocates estimated that emergency contraceptive pills (ECPs) could prevent half of all unintended pregnancies and abortions in the United States each year.
  • New recommendations out on HIV & circumcision

    Global policies are being updated with the recent issuance of recommendations from an expert consultation on male circumcision for HIV prevention.1 But what impact do the recommendations have on your practice?
  • New data emerge from the WHI: How will they impact your practice?

    Has your treatment of menopausal women changed since the initial findings released from the Women's Health Initiative (WHI) randomized, controlled trials of hormone therapy (HT)? Findings from a just-published secondary analysis of data from the WHI indicate that women who initiated HT closer to menopause tended to have reduced risk of coronary heart disease (CHD), while women further from menopause tended to have a slightly higher risk for the disease.
  • Multi-site study of potential EC in gear

    Women may have another choice in emergency contraception (EC) if a current multi-site trial of a potential candidate proves successful. HRA Pharma of Paris, France, has initiated a pivotal multicenter Phase III study to evaluate its proprietary second-generation emergency contraceptive.
  • New contraceptive ring now in advanced trials

    When you prescribe the contraceptive vaginal ring (NuvaRing, Organon; West Orange, NJ), you instruct the patient that the ring is worn for three weeks, then is removed for a one-week ring-free period. When the ring-free period is completed, a new ring must be used. But what if there was a ring that could be used for more than a three-week period?
  • Progress report: Researchers make strides in global battle against HIV

    Good news on the research front: Results from a major study indicate that treating genital herpes may help keep the AIDS virus under control in women with both infections and may reduce the spread of HIV as well.
  • CT Updates: Add colorectal cancer screening for 50+ women

    If your practice includes women ages 50 and older, be sure to remind them to be screened for colorectal cancer, advises the American College of Obstetricians and Gynecologists (ACOG).
  • Chlamydia vaccine: What is on the horizon?

    Review the number of patients who were screened and treated for chlamydia at your facility in the last two weeks. What if their infection could have been prevented by vaccine?
  • Adding vasectomies: One agency's story

    How many men enter the doors of your family planning clinic, and what services can you offer them outside of free condoms? Consider vasectomy: It is simpler, safer, less expensive, and as effective as the currently available methods of female sterilization, according to Contraceptive Technology.
  • New report underscores HPV prevalence in U.S.

    About one in four U.S. females between the ages of 14 and 59 may have human papillomavirus (HPV), according to results of the first national estimate of the infection.